Phase 4 Sjogren's Syndrome Trial, Recruiting (NCT07153276)

Phase 4 Sjogren's Syndrome Trial, Recruiting NCT07153276 Sponsor: University of Sao Paulo General Hospital Condition: Sjogren's Syndrome

Printed from Voxsanity (voxsanity.com.au) — NCT07153276 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sjogrens Syndrome

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Sjögren's disease based on recognised international classification standards from 2016.
Your Sjögren's disease is currently stable and not very active, and you are either not taking steroid medications or taking no more than 15 mg per day of prednisone.
You are currently experiencing vaginal dryness at the time of joining the study.
You are willing to take part and have signed a consent form agreeing to follow the study procedures.

Who may not be able to join:

You have a history of breast, uterine, or ovarian cancer, blood clots, or serious heart, kidney, or liver problems.
You have another autoimmune or rheumatic condition such as rheumatoid arthritis, lupus, systemic sclerosis, dermatomyositis, mixed connective tissue disease, or spondyloarthritis.
You have a condition that can look similar to Sjögren's disease, such as a history of radiation therapy to the head or neck, HIV/AIDS, hepatitis B or C, sarcoidosis, IgG4-related disease, or graft-versus-host disease (confirm with trial site if unsure whether your condition applies).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +55 11 30617492

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07153276

Sponsor: University of Sao Paulo General Hospital

Phase: Phase 4

Status: Recruiting

Condition: Sjogren's Syndrome

Trial contact: +55 11 30617492

More information: https://clinicaltrials.gov/study/NCT07153276

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Sjögren's disease based on recognised international classification standards from 2016.
Your Sjögren's disease is currently stable and not very active, and you are either not taking steroid medications or taking no more than 15 mg per day of prednisone.
You are currently experiencing vaginal dryness at the time of joining the study.
You are willing to take part and have signed a consent form agreeing to follow the study procedures.

Who may not be able to join:

You have a history of breast, uterine, or ovarian cancer, blood clots, or serious heart, kidney, or liver problems.
You have another autoimmune or rheumatic condition such as rheumatoid arthritis, lupus, systemic sclerosis, dermatomyositis, mixed connective tissue disease, or spondyloarthritis.
You have a condition that can look similar to Sjögren's disease, such as a history of radiation therapy to the head or neck, HIV/AIDS, hepatitis B or C, sarcoidosis, IgG4-related disease, or graft-versus-host disease (confirm with trial site if unsure whether your condition applies).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

University of Sao Paulo General Hospital

Registry

ClinicalTrials.gov

Start date

27 February 2026

Est. completion

27 September 2029

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Vaginal Health Index (VHI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov